Portfolio Holdings Detail for ISIN IE00BFNM3H51
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares MSCI USA ESG Screened UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker SDUS(USD) LSE
ETF Ticker SLUS(EUR) F
ETF Ticker SDUS.LS(USD) CXE
ETF Ticker SLUS.DE(EUR) CXE
ETF Ticker SDUS.L(GBP) LSE

Holdings detail for DXCM

Stock Name	DexCom Inc
Ticker	DXCM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2521311074
LEI	549300YSK3QDSFR5EU59

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44
Friday's ETF with Unusual Volume: QQH: The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32
Nasdaq 100 Movers: DXCM, FTNT: In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42
DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages: Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside: When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22
DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform: Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts: DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01
Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM): DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55
DexCom (DXCM) Q2 Revenue Jumps 15%: Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01
Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates: Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16
Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58
HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM): HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13
AVLV's Underlying Holdings Imply 10% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07
DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50
Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock: DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53
Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM): Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58
DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.: Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54
Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM): Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51
Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM): Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57
Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM): Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45
First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM): First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares MSCI USA ESG Screened UCITS ETF USD (Dist) DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Shares Held	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-09-25 (Thursday)	120,766	USD 8,248,318	USD 8,248,318	81	USD 102,080	USD 68.3	USD 67.5
2025-09-24 (Wednesday)	120,685	USD 8,146,238	USD 8,146,238
2025-09-18 (Thursday)	119,146	USD 9,028,884	USD 9,028,884	324	USD -53,870	USD 75.78	USD 76.44
2025-09-17 (Wednesday)	118,822	USD 9,082,754	USD 9,082,754	405	USD 17,933	USD 76.44	USD 76.55
2025-09-16 (Tuesday)	118,417	USD 9,064,821	USD 9,064,821	648	USD 163,840	USD 76.55	USD 75.58
2025-09-15 (Monday)	117,769	USD 8,900,981	USD 8,900,981
2025-09-12 (Friday)	117,553	USD 8,959,890	USD 8,959,890
2025-09-11 (Thursday)	117,553	USD 8,934,028	USD 8,934,028
2025-09-10 (Wednesday)	117,580	USD 8,936,080	USD 8,936,080

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DXCM by Blackrock for IE00BFNM3H51

Show aggregate share trades of DXCM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 81 68.300* 78.35
2025-09-18 BUY 324 75.780* 78.37
2025-09-17 BUY 405 76.440* 78.38
2025-09-16 BUY 648 76.550* 78.39
2025-08-15 BUY 54 80.950* 78.36
2025-08-13 BUY 27 79.960* 78.35
2025-08-08 BUY 240 78.860* 78.35
2025-08-06 BUY 507 76.400* 78.37
2025-07-31 BUY 135 80.770* 78.38
2025-07-29 BUY 540 89.350* 78.25
2025-07-11 BUY 216 83.370* 78.22
2025-07-10 BUY 243 85.460* 78.17
2025-07-09 BUY 243 84.870* 78.13
2025-07-07 SELL -162 82.940* 78.07 Profit of 12,647 on sale
2025-07-02 SELL -675 83.580* 77.97 Profit of 52,633 on sale
2025-06-27 BUY 86 86.330* 77.86
2025-06-26 BUY 81 85.040* 77.82
2025-06-24 SELL -378 87.570* 77.71 Profit of 29,375 on sale
2025-06-18 BUY 216 81.010* 77.64
2025-06-17 BUY 81 81.830* 77.61
2025-06-16 SELL -111 83.000* 77.58 Profit of 8,611 on sale
2025-06-12 SELL -135 82.850* 77.54 Profit of 10,468 on sale
2025-06-11 BUY 289 82.990* 77.50
2025-06-06 BUY 81 86.670* 77.33
2025-06-05 BUY 378 85.740* 77.27
2025-06-04 BUY 52 85.610* 77.22
2025-06-03 SELL -26 86.790* 77.15 Profit of 2,006 on sale
2025-05-30 SELL -3,172 85.800* 77.03 Profit of 244,331 on sale
2025-05-29 BUY 74 84.860* 76.97
2025-05-27 BUY 448 85.330* 76.84
2025-05-23 BUY 375 84.510* 76.72
2025-05-22 BUY 182 84.830* 76.66
2025-05-19 BUY 156 86.960* 76.44
2025-05-16 BUY 78 85.480* 76.37
2025-05-15 SELL -52 85.670* 76.30 Profit of 3,968 on sale
2025-05-14 BUY 26 86.520* 76.22
2025-05-13 BUY 52 84.110* 76.16
2025-05-12 BUY 172 85.050* 76.09
2025-05-09 SELL -130 84.670* 76.02 Profit of 9,882 on sale
2025-05-08 BUY 52 85.340* 75.94
2025-05-07 BUY 78 83.350* 75.88
2025-05-02 BUY 2,886 81.620* 75.75
2025-04-30 BUY 910 71.380* 75.83
2025-04-29 BUY 231 71.300* 75.87
2025-04-28 BUY 182 71.180* 75.91
2025-04-25 BUY 468 71.660* 75.95
2025-04-24 SELL -546 70.780* 76.00 Profit of 41,493 on sale
2025-04-23 BUY 494 66.860* 76.08
2025-04-22 BUY 208 66.330* 76.16
2025-04-17 BUY 286 68.570* 76.39
2025-04-15 BUY 260 69.230* 76.53
2025-04-11 BUY 432 66.140* 76.72
2025-04-09 BUY 162 66.840* 76.91
2025-04-08 BUY 972 60.690* 77.07
2025-04-07 BUY 318 61.630* 77.22
2025-04-04 SELL -432 59.830* 77.39 Profit of 33,433 on sale
2025-04-02 BUY 3,672 68.140* 77.49
2025-04-01 BUY 26 67.320* 77.59
2025-03-31 BUY 182 68.290* 77.69
2025-03-28 BUY 104 67.740* 77.79
2025-03-27 BUY 50 69.470* 77.88
2025-03-26 BUY 26 72.130* 77.94
2025-03-25 BUY 288 73.550* 77.98
2025-03-24 BUY 325 75.320* 78.01
2025-03-21 SELL -104 73.800* 78.06 Profit of 8,118 on sale
2025-03-20 BUY 416 75.110* 78.09
2025-03-19 BUY 75 73.380* 78.15
2025-03-18 BUY 916 70.700* 78.23
2025-03-17 BUY 182 71.350* 78.31
2025-03-14 BUY 1,352 70.690* 78.40
2025-03-13 BUY 260 68.480* 78.51
2025-03-12 SELL -1,300 70.760* 78.61 Profit of 102,189 on sale
2025-03-11 SELL -962 70.260* 78.71 Profit of 75,717 on sale
2025-03-10 BUY 286 70.720* 78.81
2025-03-07 BUY 52 77.840* 78.82
2025-03-05 BUY 390 81.960* 78.78
2025-03-04 BUY 442 82.420* 78.73
2025-03-03 BUY 832 85.990* 78.64
2025-02-28 BUY 676 88.370* 78.51
2025-02-27 SELL -130 87.810* 78.39 Profit of 10,191 on sale
2025-02-25 BUY 962 88.320* 78.10
2025-02-21 BUY 104 88.780* 77.78
2025-02-18 SELL -234 90.530* 77.25 Profit of 18,077 on sale
2025-02-14 SELL -1,586 89.070* 76.90 Profit of 121,961 on sale
2025-02-13 BUY 26 84.090* 76.79
2025-02-12 BUY 256 83.870* 76.68
2025-02-07 SELL -36 88.080* 76.15 Profit of 2,742 on sale
2025-02-06 BUY 494 88.320* 75.95
2025-02-05 BUY 130 88.780* 75.74
2025-02-04 BUY 156 87.460* 75.54
2025-02-03 BUY 156 87.050* 75.34
2025-01-31 BUY 286 86.830* 75.14
2025-01-29 SELL -26 86.430* 74.71 Profit of 1,942 on sale
2025-01-28 SELL -234 88.350* 74.46 Profit of 17,423 on sale
2025-01-27 SELL -416 87.530* 74.21 Profit of 30,871 on sale
2025-01-24 BUY 312 88.750* 73.93
2025-01-23 BUY 52 87.700* 73.66
2024-12-10 BUY 1,300 79.410* 73.55
2024-12-09 BUY 156 78.410* 73.45
2024-12-06 SELL -390 77.720* 73.36 Profit of 28,609 on sale
2024-12-05 SELL -26 78.920* 73.24 Profit of 1,904 on sale
2024-12-03 BUY 130 80.910* 72.90
2024-11-27 SELL -156 78.100* 72.36 Profit of 11,288 on sale
2024-11-26 BUY 546 77.940* 72.07
2024-11-26 BUY 546 77.940* 72.07
2024-11-25 BUY 6,400 77.830* 71.76
2024-11-25 BUY 6,400 77.830* 71.76
2024-11-22 SELL -46 72.830* 71.73 Profit of 3,300 on sale
2024-11-21 SELL -120 74.460* 71.66 Profit of 8,599 on sale
2024-11-20 SELL -48 75.240* 71.55 Profit of 3,434 on sale
2024-11-19 BUY 24 74.880* 71.45
2024-11-18 BUY 212 76.270* 71.30
2024-11-11 BUY 72 70.310* 71.26
2024-11-11 BUY 72 70.310* 71.26
2024-11-07 BUY 68 68.910* 71.55
2024-11-07 BUY 68 68.910* 71.55
2024-11-06 BUY 576 68.610* 71.81
2024-11-06 BUY 576 68.610* 71.81
2024-11-05 BUY 120 69.000* 72.08
2024-11-05 BUY 120 69.000* 72.08
2024-11-04 BUY 48 69.700* 72.33
2024-11-04 BUY 48 69.700* 72.33
2024-11-01 BUY 69 70.350* 72.56
2024-11-01 BUY 69 70.350* 72.56
2024-10-30 SELL -150 71.800* 73.00 Profit of 10,950 on sale
2024-10-30 SELL -150 71.800* 73.00 Profit of 10,950 on sale
2024-10-29 SELL -432 72.240* 73.14 Profit of 31,595 on sale
2024-10-29 SELL -432 72.240* 73.14 Profit of 31,595 on sale
2024-10-28 SELL -168 72.100* 73.37 Profit of 12,326 on sale
2024-10-28 SELL -168 72.100* 73.37 Profit of 12,326 on sale
2024-10-21 SELL -24 72.610* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	81	68.300*	78.35
2025-09-18	BUY	324	75.780*	78.37
2025-09-17	BUY	405	76.440*	78.38
2025-09-16	BUY	648	76.550*	78.39
2025-08-15	BUY	54	80.950*	78.36
2025-08-13	BUY	27	79.960*	78.35
2025-08-08	BUY	240	78.860*	78.35
2025-08-06	BUY	507	76.400*	78.37
2025-07-31	BUY	135	80.770*	78.38
2025-07-29	BUY	540	89.350*	78.25
2025-07-11	BUY	216	83.370*	78.22
2025-07-10	BUY	243	85.460*	78.17
2025-07-09	BUY	243	84.870*	78.13
2025-07-07	SELL	-162	82.940*	78.07 Profit of 12,647 on sale
2025-07-02	SELL	-675	83.580*	77.97 Profit of 52,633 on sale
2025-06-27	BUY	86	86.330*	77.86
2025-06-26	BUY	81	85.040*	77.82
2025-06-24	SELL	-378	87.570*	77.71 Profit of 29,375 on sale
2025-06-18	BUY	216	81.010*	77.64
2025-06-17	BUY	81	81.830*	77.61
2025-06-16	SELL	-111	83.000*	77.58 Profit of 8,611 on sale
2025-06-12	SELL	-135	82.850*	77.54 Profit of 10,468 on sale
2025-06-11	BUY	289	82.990*	77.50
2025-06-06	BUY	81	86.670*	77.33
2025-06-05	BUY	378	85.740*	77.27
2025-06-04	BUY	52	85.610*	77.22
2025-06-03	SELL	-26	86.790*	77.15 Profit of 2,006 on sale
2025-05-30	SELL	-3,172	85.800*	77.03 Profit of 244,331 on sale
2025-05-29	BUY	74	84.860*	76.97
2025-05-27	BUY	448	85.330*	76.84
2025-05-23	BUY	375	84.510*	76.72
2025-05-22	BUY	182	84.830*	76.66
2025-05-19	BUY	156	86.960*	76.44
2025-05-16	BUY	78	85.480*	76.37
2025-05-15	SELL	-52	85.670*	76.30 Profit of 3,968 on sale
2025-05-14	BUY	26	86.520*	76.22
2025-05-13	BUY	52	84.110*	76.16
2025-05-12	BUY	172	85.050*	76.09
2025-05-09	SELL	-130	84.670*	76.02 Profit of 9,882 on sale
2025-05-08	BUY	52	85.340*	75.94
2025-05-07	BUY	78	83.350*	75.88
2025-05-02	BUY	2,886	81.620*	75.75
2025-04-30	BUY	910	71.380*	75.83
2025-04-29	BUY	231	71.300*	75.87
2025-04-28	BUY	182	71.180*	75.91
2025-04-25	BUY	468	71.660*	75.95
2025-04-24	SELL	-546	70.780*	76.00 Profit of 41,493 on sale
2025-04-23	BUY	494	66.860*	76.08
2025-04-22	BUY	208	66.330*	76.16
2025-04-17	BUY	286	68.570*	76.39
2025-04-15	BUY	260	69.230*	76.53
2025-04-11	BUY	432	66.140*	76.72
2025-04-09	BUY	162	66.840*	76.91
2025-04-08	BUY	972	60.690*	77.07
2025-04-07	BUY	318	61.630*	77.22
2025-04-04	SELL	-432	59.830*	77.39 Profit of 33,433 on sale
2025-04-02	BUY	3,672	68.140*	77.49
2025-04-01	BUY	26	67.320*	77.59
2025-03-31	BUY	182	68.290*	77.69
2025-03-28	BUY	104	67.740*	77.79
2025-03-27	BUY	50	69.470*	77.88
2025-03-26	BUY	26	72.130*	77.94
2025-03-25	BUY	288	73.550*	77.98
2025-03-24	BUY	325	75.320*	78.01
2025-03-21	SELL	-104	73.800*	78.06 Profit of 8,118 on sale
2025-03-20	BUY	416	75.110*	78.09
2025-03-19	BUY	75	73.380*	78.15
2025-03-18	BUY	916	70.700*	78.23
2025-03-17	BUY	182	71.350*	78.31
2025-03-14	BUY	1,352	70.690*	78.40
2025-03-13	BUY	260	68.480*	78.51
2025-03-12	SELL	-1,300	70.760*	78.61 Profit of 102,189 on sale
2025-03-11	SELL	-962	70.260*	78.71 Profit of 75,717 on sale
2025-03-10	BUY	286	70.720*	78.81
2025-03-07	BUY	52	77.840*	78.82
2025-03-05	BUY	390	81.960*	78.78
2025-03-04	BUY	442	82.420*	78.73
2025-03-03	BUY	832	85.990*	78.64
2025-02-28	BUY	676	88.370*	78.51
2025-02-27	SELL	-130	87.810*	78.39 Profit of 10,191 on sale
2025-02-25	BUY	962	88.320*	78.10
2025-02-21	BUY	104	88.780*	77.78
2025-02-18	SELL	-234	90.530*	77.25 Profit of 18,077 on sale
2025-02-14	SELL	-1,586	89.070*	76.90 Profit of 121,961 on sale
2025-02-13	BUY	26	84.090*	76.79
2025-02-12	BUY	256	83.870*	76.68
2025-02-07	SELL	-36	88.080*	76.15 Profit of 2,742 on sale
2025-02-06	BUY	494	88.320*	75.95
2025-02-05	BUY	130	88.780*	75.74
2025-02-04	BUY	156	87.460*	75.54
2025-02-03	BUY	156	87.050*	75.34
2025-01-31	BUY	286	86.830*	75.14
2025-01-29	SELL	-26	86.430*	74.71 Profit of 1,942 on sale
2025-01-28	SELL	-234	88.350*	74.46 Profit of 17,423 on sale
2025-01-27	SELL	-416	87.530*	74.21 Profit of 30,871 on sale
2025-01-24	BUY	312	88.750*	73.93
2025-01-23	BUY	52	87.700*	73.66
2024-12-10	BUY	1,300	79.410*	73.55
2024-12-09	BUY	156	78.410*	73.45
2024-12-06	SELL	-390	77.720*	73.36 Profit of 28,609 on sale
2024-12-05	SELL	-26	78.920*	73.24 Profit of 1,904 on sale
2024-12-03	BUY	130	80.910*	72.90
2024-11-27	SELL	-156	78.100*	72.36 Profit of 11,288 on sale
2024-11-26	BUY	546	77.940*	72.07
2024-11-26	BUY	546	77.940*	72.07
2024-11-25	BUY	6,400	77.830*	71.76
2024-11-25	BUY	6,400	77.830*	71.76
2024-11-22	SELL	-46	72.830*	71.73 Profit of 3,300 on sale
2024-11-21	SELL	-120	74.460*	71.66 Profit of 8,599 on sale
2024-11-20	SELL	-48	75.240*	71.55 Profit of 3,434 on sale
2024-11-19	BUY	24	74.880*	71.45
2024-11-18	BUY	212	76.270*	71.30
2024-11-11	BUY	72	70.310*	71.26
2024-11-11	BUY	72	70.310*	71.26
2024-11-07	BUY	68	68.910*	71.55
2024-11-07	BUY	68	68.910*	71.55
2024-11-06	BUY	576	68.610*	71.81
2024-11-06	BUY	576	68.610*	71.81
2024-11-05	BUY	120	69.000*	72.08
2024-11-05	BUY	120	69.000*	72.08
2024-11-04	BUY	48	69.700*	72.33
2024-11-04	BUY	48	69.700*	72.33
2024-11-01	BUY	69	70.350*	72.56
2024-11-01	BUY	69	70.350*	72.56
2024-10-30	SELL	-150	71.800*	73.00 Profit of 10,950 on sale
2024-10-30	SELL	-150	71.800*	73.00 Profit of 10,950 on sale
2024-10-29	SELL	-432	72.240*	73.14 Profit of 31,595 on sale
2024-10-29	SELL	-432	72.240*	73.14 Profit of 31,595 on sale
2024-10-28	SELL	-168	72.100*	73.37 Profit of 12,326 on sale
2024-10-28	SELL	-168	72.100*	73.37 Profit of 12,326 on sale
2024-10-21	SELL	-24	72.610*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	2,244,349	123,900	7,301,108	30.7%
2025-09-18	2,096,398	2,923	4,473,314	46.9%
2025-09-17	1,005,017	909	2,841,630	35.4%
2025-09-16	832,635	1,252	1,662,428	50.1%
2025-09-15	415,979	19,554	1,507,100	27.6%
2025-09-12	479,180	25	1,013,014	47.3%
2025-09-11	1,239,171	19	3,292,844	37.6%
2025-09-10	778,899	1	2,102,775	37.0%
2025-09-09	398,555	48,137	1,042,556	38.2%
2025-09-08	597,379	10,948	1,743,480	34.3%
2025-09-05	490,229	0	992,181	49.4%
2025-09-04	833,267	24	1,699,659	49.0%
2025-09-03	1,673,104	582	3,096,450	54.0%
2025-09-02	559,125	6,032	1,379,296	40.5%
2025-08-29	395,483	819	767,429	51.5%
2025-08-28	480,565	39	1,612,270	29.8%
2025-08-27	422,875	756	1,106,762	38.2%
2025-08-26	451,911	15,387	1,316,342	34.3%
2025-08-25	801,886	5,802	2,158,071	37.2%
2025-08-22	279,355	5	826,312	33.8%
2025-08-21	331,378	4,639	798,573	41.5%
2025-08-20	491,337	399	1,003,276	49.0%
2025-08-19	311,145	1,383	842,816	36.9%
2025-08-18	509,896	0	1,182,266	43.1%
2025-08-15	351,714	12,102	630,748	55.8%
2025-08-14	394,332	438	858,593	45.9%
2025-08-13	530,063	302	1,270,620	41.7%
2025-08-12	533,812	115	1,296,848	41.2%
2025-08-11	673,352	144	1,432,682	47.0%
2025-08-08	812,111	647	1,314,352	61.8%
2025-08-07	679,883	11	1,091,906	62.3%
2025-08-06	902,331	283	2,029,615	44.5%
2025-08-05	598,249	68	2,057,698	29.1%
2025-08-04	942,525	17	3,002,291	31.4%
2025-08-01	1,104,059	1,225	2,117,218	52.1%
2025-07-31	1,973,583	3,744	3,201,771	61.6%
2025-07-30	484,427	82	1,520,136	31.9%
2025-07-29	414,317	112	885,534	46.8%
2025-07-28	545,711	900	1,158,616	47.1%
2025-07-25	439,501	851	1,018,375	43.2%
2025-07-24	314,578	49	750,090	41.9%
2025-07-23	342,609	311	689,820	49.7%
2025-07-22	354,194	17,613	750,057	47.2%
2025-07-21	308,164	9,508	783,241	39.3%
2025-07-18	312,697	18,442	836,608	37.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares MSCI USA ESG Screened UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	SDUS(USD) LSE
ETF Ticker	SLUS(EUR) F
ETF Ticker	SDUS.LS(USD) CXE
ETF Ticker	SLUS.DE(EUR) CXE
ETF Ticker	SDUS.L(GBP) LSE